Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04609657
Other study ID # PEP-2002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 10, 2020
Est. completion date May 25, 2021

Study information

Verified date March 2022
Source PepsiCo Global R&D
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a double-blind, controlled, parallel, randomized sensory study. The study will consist of two cohorts; habitual regular full-calorie Carbonated Soft Drink (CSD) consumers and habitual low-calorie CSD consumers. Each cohort will be randomized to one of 3 interventions for six months (24 weeks): - Intervention 1: Control (full sweetness) beverage - Intervention 2: Step-wise sweetness reduction series of beverages - Intervention 3: Moderate sweetness (reduced sweetness) beverage The primary outcome is to assess the perception changes in sweetness (magnitude scale) and sweetness liking (Likert scale) of a test product and a control product over a period of six months. The study endeavors to explore whether consumers of sweetened carbonated beverages can adapt liking to lower sweetness beverages after prolonged exposure of daily consumption of beverages with step-wise reduction of sweetness, or maintenance at reduced (moderate) sweetness. Additional analysis will be to assess dietary compensation for sweetness in the step-wise and moderate reduction arms compared to the control arms (the full calorie and low calorie control beverages). Dietary analysis of calories and intakes of total sugar, added sugar, and servings of low-/non-calorie sweeteners will be assessed using a 3-day diet record pre-intervention and monthly for 6 months.


Recruitment information / eligibility

Status Completed
Enrollment 168
Est. completion date May 25, 2021
Est. primary completion date May 25, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 55 Years
Eligibility Inclusion Criteria: 1. Healthy adults 25-55 years of age 2. Habitually consume regular or diet CSD 3. Willing and able to consume at least one orange CSD beverage daily for a total of 6 months and abstain from other sweetened beverages 4. Willing and able to complete questionnaires regarding dietary intake and sensory perception 5. Has internet access via computer, phone or other device and is able to maintain internet access throughout the trial in order to complete daily online questionnaires 6. Participant is judged to be in good health based on a verbal health query and the general health and lifestyle questionnaire 7. Participant is willing to maintain his or her habitual diet, smoking habits and physical activity patterns, including habitual use of study approved medications and/or dietary supplements throughout the study period 8. Participant understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators Exclusion Criteria: 1. Regular smoker (more than 1 cigarette per week) 2. History or presence of type 1 or 2 diabetes mellitus 3. Extreme dietary habits, including but not limited to vegetarian diets and intentional consumption of a high fiber diet, gluten-free, low-carb, vegan, ketogenic, and intermittent fasting (defined as intentional fasting for longer than 16 hours or alternate day fasting) 4. Extreme changes to physical activity 5. Female who is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential and is unwilling to commit to the use of a medically approved form of contraception throughout the study period 6. Recent history (within 12 months of screening; Visit 1) of alcohol or substance abuse. Alcohol abuse is defined as >14 drinks per week (1 drink = 12 oz beer, 5 oz wine, or 1½ oz distilled spirits) 7. Individual has a condition the Clinical Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, or which might confound the interpretation of the study results or put the participant at undue risk 8. Dislike of citrus flavored CSDs 9. Participation in another clinical trial within past 30 days 10. People who have phenylketonuria (low calorie sweetened beverages contain aspartame)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Flavored carbonated soft drink (CSD)
Beverage

Locations

Country Name City State
United States BioFortis Innovation Services Addison Illinois

Sponsors (1)

Lead Sponsor Collaborator
PepsiCo Global R&D

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Dietary compensation for sweetness 3-day diet record to assess calories and intake of total sugar, added sugar, low-/non calorie sweeteners Changes over a period of 6 months, measured at monthly intervals from month 0 (baseline) to month 6
Primary Sweetness liking Likert Scale, 9 point scale from 1=Dislike extremely to 9=Like extremely Changes over a period of 6 months, measured at monthly intervals from month 0 (baseline) to month 6
Primary Sweetness intensity perception Magnitude scale ranging from Barely perceptible to Strongest imaginable sweetness Changes over a period of 6 months, measured at monthly intervals from month 0 (baseline) to month 6
See also
  Status Clinical Trial Phase
Terminated NCT04284462 - Liking Adaptation to Beverages of Varying Sweetness Levels After Prolonged Exposure N/A
Completed NCT05010408 - Liking Adaptation to Beverages of Varying Sweetness Levels Following Prolonged Exposure N/A